Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
出版年份 2014 全文链接
标题
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
作者
关键词
-
出版物
Blood Cancer Journal
Volume 4, Issue 6, Pages e218-e218
出版商
Springer Nature
发表日期
2014-06-13
DOI
10.1038/bcj.2014.39
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
- (2013) J. M. Rowe et al. BLOOD
- The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML
- (2013) N. Shayegi et al. BLOOD
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia
- (2013) Brigitte Mohr et al. BRITISH JOURNAL OF HAEMATOLOGY
- Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system
- (2013) C Arndt et al. LEUKEMIA
- Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells
- (2013) C Arndt et al. LEUKEMIA
- Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia
- (2012) Keumrock Hwang et al. ANNALS OF HEMATOLOGY
- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
- (2012) R. B. Walter et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct
- (2012) M Aigner et al. LEUKEMIA
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
- (2012) A K Burnett et al. LEUKEMIA
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations
- (2011) Roberta Riccioni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
- (2011) Nicolas Goardon et al. CANCER CELL
- High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation
- (2011) M. S. De Propris et al. HAEMATOLOGICA
- Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System
- (2011) Christoph Röllig et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytarabine Dose of 36 g/m2Compared With 12 g/m2Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study
- (2011) Markus Schaich et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells
- (2010) Christoph Stein et al. BRITISH JOURNAL OF HAEMATOLOGY
- A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting
- (2010) Markus Kügler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Current and emerging therapies for acute myeloid leukemia
- (2010) Tadeusz Robak et al. CLINICAL THERAPEUTICS
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
- (2009) B. Cate et al. CURRENT DRUG TARGETS
- HLA-DRnegpatients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia
- (2009) Uta Oelschlaegel et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Anthracycline Dose Intensification in Acute Myeloid Leukemia
- (2009) Hugo F. Fernandez et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD33 Detection by Immunohistochemistry in Paraffin-Embedded Tissues
- (2008) James D. Hoyer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Persistence of CD33 expression at relapse in CD33+acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease
- (2008) Patrice Chevallier et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor
- (2008) Roberta Riccioni et al. BRITISH JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now